Entasis Therapeutics Holdings Inc
(ETTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 7,000 | 0 | 0 | 0 | 0 |
| Gross Profit | 7,000 | N/A | N/A | N/A | N/A |
| Operating Expenses | 11,127 | 14,098 | 14,191 | 9,251 | 10,161 |
| Operating Income | -4,127 | -14,098 | -14,191 | -9,251 | -10,161 |
| Other Income | 966 | 789 | 1,321 | 1,172 | 1,688 |
| Pre-tax Income | -3,161 | -13,309 | -12,870 | -8,079 | -8,473 |
| Income Tax | 324 | 73 | 71 | N/A | N/A |
| Net Income Continuous | -3,485 | -13,382 | -12,941 | -8,079 | -8,473 |
| Net Income | $-3,485 | $-13,382 | $-12,941 | $-8,079 | $-8,473 |
| EPS Basic Total Ops | -0.27 | -1.02 | -0.99 | 1,305.63 | -20.33 |
| EPS Basic Continuous Ops | -0.27 | -1.02 | -0.99 | 1,274.27 | -9.77 |
| EPS Diluted Total Ops | -0.27 | -1.02 | -0.99 | 1,305.63 | -20.33 |
| EPS Diluted Continuous Ops | -0.27 | -1.02 | -0.99 | 1,274.27 | -9.77 |
| EBITDA(a) | $-4,259 | $-14,297 | $-14,346 | $-9,233 | $-10,125 |